PL359918A1 - 4-aminochinazoliny - Google Patents
4-aminochinazolinyInfo
- Publication number
- PL359918A1 PL359918A1 PL01359918A PL35991801A PL359918A1 PL 359918 A1 PL359918 A1 PL 359918A1 PL 01359918 A PL01359918 A PL 01359918A PL 35991801 A PL35991801 A PL 35991801A PL 359918 A1 PL359918 A1 PL 359918A1
- Authority
- PL
- Poland
- Prior art keywords
- quinazolines
- amino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/94—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US66611700A | 2000-09-20 | 2000-09-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL359918A1 true PL359918A1 (pl) | 2004-09-06 |
Family
ID=24672900
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL01359918A PL359918A1 (pl) | 2000-09-20 | 2001-09-17 | 4-aminochinazoliny |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20040044204A1 (pl) |
| EP (1) | EP1318985A2 (pl) |
| JP (1) | JP2004509875A (pl) |
| KR (1) | KR20030061807A (pl) |
| CN (1) | CN1474816A (pl) |
| AU (1) | AU2002213923A1 (pl) |
| BR (1) | BR0114021A (pl) |
| CA (1) | CA2422560A1 (pl) |
| HU (1) | HUP0302429A3 (pl) |
| MX (1) | MXPA03002411A (pl) |
| NO (1) | NO20031267L (pl) |
| PL (1) | PL359918A1 (pl) |
| WO (1) | WO2002024666A2 (pl) |
| ZA (1) | ZA200303069B (pl) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002212697A1 (en) * | 2000-11-02 | 2002-05-15 | Nippon Shinyaku Co. Ltd. | Quinazoline derivatives and drugs |
| PE20030008A1 (es) | 2001-06-19 | 2003-01-22 | Bristol Myers Squibb Co | Inhibidores duales de pde 7 y pde 4 |
| US7829566B2 (en) | 2001-09-17 | 2010-11-09 | Werner Mederski | 4-amino-quinazolines |
| AU2003255482A1 (en) * | 2002-10-02 | 2004-04-23 | Merck Patent Gmbh | Use of 4 amino-quinazolines as anti cancer agents |
| US8309562B2 (en) | 2003-07-03 | 2012-11-13 | Myrexis, Inc. | Compounds and therapeutical use thereof |
| US20050209438A1 (en) * | 2004-03-19 | 2005-09-22 | Browne Edward P | Starter feed stream acidification in DMC-catalyzed process |
| US8258145B2 (en) | 2005-01-03 | 2012-09-04 | Myrexis, Inc. | Method of treating brain cancer |
| CA2592900A1 (en) | 2005-01-03 | 2006-07-13 | Myriad Genetics Inc. | Nitrogen containing bicyclic compounds and therapeutical use thereof |
| US7473884B2 (en) * | 2005-04-21 | 2009-01-06 | Avago Technologies Ecbu Ip (Singapore) Pte. Ltd. | Orientation determination utilizing a cordless device |
| KR100728763B1 (ko) * | 2005-12-13 | 2007-06-19 | 주식회사 에스티넷 | Ｐｏｎ 또는 ａｏｎ 방식의 방송/통신 융합 ｆｔｔｈ시스템 |
| LT3575288T (lt) | 2009-09-03 | 2021-12-10 | Bristol-Myers Squibb Company | Chinazolinai kaip kalio jonų kanalų inhibitoriai |
| CN102146076B (zh) * | 2010-02-05 | 2013-12-25 | 陕西师范大学 | 苯胺喹唑啉衍生物及其制备方法 |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US14679A (en) * | 1856-04-15 | Joel h | ||
| US55514A (en) * | 1866-06-12 | Improved machine for tunneling rock | ||
| US44442A (en) * | 1864-09-27 | Dayid nelson | ||
| US3970648A (en) * | 1974-09-06 | 1976-07-20 | Diamond Shamrock Corporation | 2-[2-(5-Nitro-2-furyl)vinyl]-4-(anilino)quinazolines |
| US3973021A (en) * | 1974-09-06 | 1976-08-03 | Diamond Shamrock Corporation | 2-[2-(5-Nitro-2-furyl)vinyl]-4-(phydroxyanilino)quinazoline as a bactericide |
| US3974277A (en) * | 1974-09-06 | 1976-08-10 | Diamond Shamrock Corporation | 2-[2-(5-Nitro-2-furyl)vinyl]-4-(anilino)quinazolines as growth promotants and feed efficiency enhancing agents |
| US4642347A (en) * | 1985-05-21 | 1987-02-10 | American Home Products Corporation | 3(2-quinolinylalkoxy)phenols |
| IL89029A (en) * | 1988-01-29 | 1993-01-31 | Lilly Co Eli | Fungicidal quinoline and cinnoline derivatives, compositions containing them, and fungicidal methods of using them |
| US4952567A (en) * | 1988-05-09 | 1990-08-28 | City Of Hope | Inhibition of lipogenesis |
| JP3531944B2 (ja) * | 1991-02-07 | 2004-05-31 | アベンティス・ファーマ・ソシエテ・アノニム | 新規のベンジル基で置換された窒素系二環式誘導体及びその製造方法 |
| MX9200299A (es) * | 1991-02-07 | 1992-12-01 | Roussel Uclaf | Nuevos derivados biciclicos nitrogenados, su procedimiento de preparacion los nuevos compuestos intermedios obtenidos su aplicacion como medicamentos y las composiciones farmaceuticas que los contienen. |
| US6004979A (en) * | 1991-02-07 | 1999-12-21 | Hoechst Marion Roussel | Nitrogenous bicycles |
| US5245036A (en) * | 1992-05-07 | 1993-09-14 | Dowelanco | Process for the preparation of 4-phenoxyquinoline compounds |
| US5972598A (en) * | 1992-09-17 | 1999-10-26 | Board Of Trustess Of The University Of Illinois | Methods for preventing multidrug resistance in cancer cells |
| EP1195372A1 (en) * | 1994-04-18 | 2002-04-10 | Mitsubishi Pharma Corporation | N-heterocyclic substituted benzamide derivatives with antihypertensive activity |
| US5840695A (en) * | 1994-10-07 | 1998-11-24 | Heska Corporation | Ectoparasite saliva proteins and apparatus to collect such proteins |
| US5598994A (en) * | 1995-06-29 | 1997-02-04 | Panduit Corp. | Stud engaging device |
| US5906819A (en) * | 1995-11-20 | 1999-05-25 | Kirin Beer Kabushiki Kaisha | Rho target protein Rho-kinase |
| DE19608653A1 (de) * | 1996-03-06 | 1997-09-11 | Thomae Gmbh Dr K | Pyrimido[5,4-d]pyrimidine, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung |
| ID19609A (id) * | 1996-07-13 | 1998-07-23 | Glaxo Group Ltd | Senyawa-senyawa heterosiklik |
| EP0956865B2 (en) * | 1996-08-12 | 2010-08-18 | Mitsubishi Tanabe Pharma Corporation | MEDICINES COMPRISING Rho KINASE INHIBITOR |
| US5885803A (en) * | 1997-06-19 | 1999-03-23 | Incyte Pharmaceuticals, Inc. | Disease associated protein kinases |
| ZA986729B (en) * | 1997-07-29 | 1999-02-02 | Warner Lambert Co | Irreversible inhibitors of tyrosine kinases |
| WO1999009986A1 (fr) * | 1997-08-22 | 1999-03-04 | Kyowa Hakko Kogyo Co., Ltd. | Derives de 4-aminoquinazoline |
| US20020025968A1 (en) * | 1998-04-15 | 2002-02-28 | Rifat Pamukcu | Method for inhibiting neoplastic cells and related conditions by exposure to 4-aminoquinazoline derivatives |
| US6184226B1 (en) * | 1998-08-28 | 2001-02-06 | Scios Inc. | Quinazoline derivatives as inhibitors of P-38 α |
| US6080747A (en) * | 1999-03-05 | 2000-06-27 | Hughes Institute | JAK-3 inhibitors for treating allergic disorders |
| US6890930B1 (en) * | 1999-09-28 | 2005-05-10 | 3-Dimensional Pharmaceuticals, Inc. | Quinazolinones |
| US6794389B2 (en) * | 2000-03-31 | 2004-09-21 | Nippon Shinyaku Co., Ltd. | Quinazoline derivatives and drugs |
-
2001
- 2001-09-17 CA CA002422560A patent/CA2422560A1/en not_active Abandoned
- 2001-09-17 PL PL01359918A patent/PL359918A1/pl unknown
- 2001-09-17 US US10/380,909 patent/US20040044204A1/en not_active Abandoned
- 2001-09-17 EP EP01982300A patent/EP1318985A2/en not_active Withdrawn
- 2001-09-17 WO PCT/EP2001/010704 patent/WO2002024666A2/en not_active Application Discontinuation
- 2001-09-17 HU HU0302429A patent/HUP0302429A3/hu unknown
- 2001-09-17 KR KR10-2003-7004020A patent/KR20030061807A/ko not_active Application Discontinuation
- 2001-09-17 CN CNA018190782A patent/CN1474816A/zh active Pending
- 2001-09-17 MX MXPA03002411A patent/MXPA03002411A/es unknown
- 2001-09-17 AU AU2002213923A patent/AU2002213923A1/en not_active Abandoned
- 2001-09-17 BR BR0114021-3A patent/BR0114021A/pt not_active Application Discontinuation
- 2001-09-17 JP JP2002529076A patent/JP2004509875A/ja active Pending
-
2003
- 2003-03-19 NO NO20031267A patent/NO20031267L/no not_active Application Discontinuation
- 2003-04-17 ZA ZA200303069A patent/ZA200303069B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1318985A2 (en) | 2003-06-18 |
| NO20031267L (no) | 2003-05-19 |
| JP2004509875A (ja) | 2004-04-02 |
| ZA200303069B (en) | 2004-07-19 |
| HUP0302429A2 (hu) | 2003-10-28 |
| US20040044204A1 (en) | 2004-03-04 |
| WO2002024666A3 (en) | 2002-09-26 |
| BR0114021A (pt) | 2003-08-19 |
| WO2002024666A2 (en) | 2002-03-28 |
| KR20030061807A (ko) | 2003-07-22 |
| CN1474816A (zh) | 2004-02-11 |
| NO20031267D0 (no) | 2003-03-19 |
| CA2422560A1 (en) | 2002-03-28 |
| HUP0302429A3 (en) | 2004-01-28 |
| MXPA03002411A (es) | 2003-06-19 |
| AU2002213923A1 (en) | 2002-04-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60105852D1 (en) | Fluidmischsystem | |
| DE50112082D1 (en) | Bulk-acoustic-wave-filter | |
| DE60115644D1 (en) | Thiazinoxazolidinon | |
| DE60121590D1 (en) | Pyrazolderivate | |
| AU3391801A (en) | Pyridinylimidazoles | |
| DE60128102D1 (en) | Imidazolderivate | |
| AU8274301A (en) | Electro-powder | |
| DE50104081D1 (en) | Hydrolager | |
| DE50105205D1 (en) | Creatinin-biosensor | |
| DE60114954D1 (en) | Polytrimethylenterephthalatgarn | |
| AU6803901A (en) | Bis-arylsulfones | |
| DE50112740D1 (en) | Strangführungselement | |
| DE50110569D1 (en) | Substituierte c-cyclohexylmethylamin-derivate | |
| DE60120222D1 (en) | Laser-anemometer | |
| DE50107376D1 (en) | Orientierte acrylathotmelts | |
| DE50112014D1 (en) | Stiftheizer | |
| DE50102859D1 (en) | Hochfliessfähige propylenblockcopolymerisate | |
| AU9385201A (en) | Sulfonylguanidine | |
| DE50107703D1 (en) | Creatininsensor-kalibration | |
| DE50008626D1 (en) | Substituierte aminomethyl-phenyl-cyclohexanderivate | |
| AU6619001A (en) | Liquid-pourers | |
| DE60114837D1 (en) | Signalmessung | |
| DE50114303D1 (en) | Nsaugluftkanal | |
| DE50008447D1 (en) | Aminomethyl-phenyl-cyclohexanonderivate | |
| DE50114375D1 (en) | Compound-reibungsvakuumpumpe |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DISC | Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications) |